In Vitro Bioactivity of a Recombinant Human Collagen Peptide in a Filler Biomimetic Skin Model
Open Access
- 12 December 2025
- journal article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (12) , e70592
Abstract
Background: Recombinant human collagen peptides (rhCol peptides) have demonstrated considerable promise in various biomedical applications, including wound healing, dermatological treatments, aesthetic procedures, cosmetic formulations, and personal healthcare. Recently, their incorporation as a bioactive component in dermal filler products has gained significant attraction within the aesthetic and cosmetic fields. Aims: To elucidate the beneficial bio‐efficacy of rhCol peptides as a dermal filler, underlying mechanisms from both the cell and tissue levels were explored. Methods: The stimulatory effect of rhCol peptides on extracellular matrix (ECM) production was confirmed in 2D human fibroblast cultures at mRNA levels. Subsequently, its impact on skin rejuvenation was illustrated, utilizing a novel, in‐house developed 3D in vitro filler biomimetic skin model, tissue morphology, epidermal proliferation and differentiation, as well as dermal ECM deposition were investigated. Transcriptomic analysis further offered an in‐depth view of molecular pathways underlying the phenotypical change observed at cellular and tissue levels. Results: In the 2D cell model, matrix remodeling–related genes such as Collagen type I and III, Elastin, Fibrillin 1, Hyaluronic acid synthases 1, 2, and 3 were significantly upregulated upon treatment with rhCol III peptides. Its direct binding to the dermal scaffold was confirmed within a novel filler biomimetic in vitro skin model, providing compelling evidence of their beneficial effects on both epidermal and dermal compartments, embodied in improved epidermis regeneration (Ki67, COL17A1) and dermis remodeling (FBN1 and glycosaminoglycans). Furthermore, transcriptomic analysis provided valuable insights into the potential mechanisms of downregulated inflammation, senescence and apoptosis; upregulated integrin binding; and extracellular matrix formation resulted from the binding of rhCol III peptides to the dermal scaffold. Conclusions: These findings collectively support the pro‐ECM potential of such rhCol III peptides as a promising biomaterial for dermal filler, as well as potential cosmetic applications. Limited by the gap between in vitro mimetic model and real injection, further clinical trials should be taken to reconfirm the potential benefits.Keywords
This publication has 36 references indexed in Scilit:
- The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo‐controlled clinical trialsJournal of Cosmetic Dermatology, 2015
- Collagen matrix as a tool in studying fibroblastic cell behaviorCell Adhesion & Migration, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Use of collagen as a biomaterial: An updateJournal of Indian Society of Periodontology, 2013
- Collagen‐derived dipeptide, proline‐hydroxyproline, stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblastsThe Journal of Dermatology, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Effect of Collagen Oligopeptide Injection on Rabbit TenositisJournal of Veterinary Medical Science, 2008
- Collagens—structure, function, and biosynthesisAdvanced Drug Delivery Reviews, 2003
- Gene Ontology: tool for the unification of biologyNature Genetics, 2000
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 1999